Antony Mattessich

Antony Mattessich

DirectoratOcular Therapeutix· In proxies 2022–2025

Pay in FY2024+168% from the year before · Ocular Therapeutix stock +91.5% the same year

Antony Mattessich was paid $8.8M in FY2024 (Dec), up 168%. Ocular Therapeutix stock rose 91.5% that year.

Pay$100 in the stock at the end of FY21 → $123
Pay is from the Summary Compensation Table of each Ocular Therapeutix proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aura BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Ocular TherapeutixPublic company · 4 yr
    • Former President and Chief Executive Officer2022 – Present · 4 yrStock in role +6%

Roles come from the proxy statements of each company.

Boards1

  • Aura BiosciencesDirector · 4 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?